Literature DB >> 14670333

IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway.

Cristina T Fonseca1, Cristiana F A Brito, José B Alves, Sergio C Oliveira.   

Abstract

Herein, we tested the ability of IL-12 to enhance protection induced by recombinant Sm14 (rSm14). Mice immunization with three doses of 25 microg of rSm14 was able to induce 25% of protection in mice against challenge. However, co-administration of exogenous IL-12 enhanced protective immunity engendered by rSm14 from 25 to 42.2%. Higher levels of IgG2a and TNF-alpha were observed in mice immunized with rSm14 plus IL-12 compared to animals vaccinated with rSm14 alone. Regarding other cytokines, significant amounts of IFN-gamma were measured in splenocyte culture supernatants of rSm14/IL-12 or rSm14 vaccinated mice and no IL-4 was detected. In an attempt to determine the role of IFN-gamma and TNF-alpha in IL-12 induced immunity, IFN-gamma and TNFR-p55 knockout mice were immunized with rSm14/IL-12 and no protection was achieved. Therefore, protection induced by rSm14/IL-12 was shown to be dependent on endogenous IFN-gamma and TNF-alpha. Although, rSm14 immunization induced partial protection, reduction of hepatic granuloma area was only observed when IL-12 was co-administered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670333     DOI: 10.1016/j.vaccine.2003.07.010

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  28 in total

1.  Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.

Authors:  Avi-Hai Hovav; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.

Authors:  F C Cardoso; R N A Pacífico; R A Mortara; S C Oliveira
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  Ultrastructural changes of adult Schistosoma mansoni worms recovered from C57BL/6 mice passively immunized with normal and vaccinated rabbit sera in vivo.

Authors:  Sherif H Abdeen; Enayat S Reda; Eman A El-Shabasy; Allal Ouhtit
Journal:  Parasitol Res       Date:  2011-05-26       Impact factor: 2.289

4.  Construction and expression of bivalent membrane-anchored DNA vaccine encoding Sjl4FABP and Sj26GST genes.

Authors:  Ping Guo; Wuxing Dai; Shuojie Liu; Ping Yang; Jizhong Cheng; Liang Liang; Zhihao Chen; Hong Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

5.  Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice.

Authors:  Maysa Ahmad Eraky; Asmaa Abd El-Monem El-Kholy; Gehan Abd El-Rahman Rashed; Olfat Ali Hammam; Ahlam Farag Moharam; Eman Abdel-Rahman Abou-Ouf; Nagwa Shaban Mohammed Aly; Shereen Magdy Kishik; Karim Fetouh Abdallah; Dalia Ibrahim Hamdan
Journal:  Parasitol Res       Date:  2016-06-20       Impact factor: 2.289

6.  Transmission electron microscopic observations on ultrastructural alterations in Schistosoma mansoni adult worms recovered from C57BL/6 mice treated with radiation-attenuated vaccine and/or praziquantel in addition to passive immunization with normal and vaccinated rabbit sera against infection.

Authors:  Eman A El-Shabasy; Enayat S Reda; Sherif H Abdeen; Ashraf E Said; Allal Ouhtit
Journal:  Parasitol Res       Date:  2015-02-18       Impact factor: 2.289

7.  Structural changes of Schistosoma mansoni adult worms recovered from C57BL/6 mice treated with radiation-attenuated vaccine and/or praziquantel against infection.

Authors:  Enayat S Reda; Allal Ouhtit; Sherif H Abdeen; Eman A El-Shabasy
Journal:  Parasitol Res       Date:  2011-08-09       Impact factor: 2.289

8.  The effects of interleukin (IL)-12 and IL-4 deficiency on worm development and granuloma formation in Schistosoma japonicum-infected mice.

Authors:  Yu-Li Cheng; Wen-Jian Song; Wen-Qi Liu; Jia-Hui Lei; Zheng Kong; Yong-Long Li
Journal:  Parasitol Res       Date:  2011-06-28       Impact factor: 2.289

9.  Effect of regulatory T cells on the efficacy of the fatty acid-binding protein vaccine against Schistosoma japonicum.

Authors:  Chun-Lian Tang; Rong-Hui Zhang; Zhi-Ming Liu; Huang Jin; Long He
Journal:  Parasitol Res       Date:  2019-01-04       Impact factor: 2.289

Review 10.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.